Bafna Pharmaceuticals Limited — Important, 31-03-2025: Updates

M/s. SRJR Lifesciences LLP, a promoter of Bafna Pharmaceuticals Limited, has sold 31,45,296 equity shares of the company through an Offer for Sale via the stock exchange mechanism. This transaction occurred on March 27 and March 28, 2025. The sale aligns with SEBI's regulations, aimed at promoting transparency in insider trading activities. Shareholders should monitor the situation closely, as large share disposals by promoters can influence market sentiment and stock performance.